Clinical Study
Comparison of Survival in Patients with Isolated Peritoneal Carcinomatosis from Colorectal Cancer Treated with Cytoreduction and Melphalan or Mitomycin-C as Hyperthermic Intraperitoneal Chemotherapy Agent
Figure 2
Progression-free survival of patients with PC from CRC treated with CRS/HIPEC.